Insulet Corporation PODD

PODD Company Overview

Insulet Corporation is a U.S.-based medical device company focused on the development, manufacturing, and commercialization of insulin delivery systems for people with diabetes. The company operates primarily within the diabetes technology and medical devices industries, with its core business centered on wearable, tubeless insulin pump systems under the Omnipod brand. Insulet generates most of its revenue from recurring sales of disposable insulin pods and related diabetes management products, supported by hardware controllers and software integration capabilities. Its customer base includes people with Type 1 diabetes, insulin-dependent Type 2 diabetes patients, healthcare providers, pharmacies, and healthcare systems.

The company was founded in 2000 and is headquartered in Acton, Massachusetts. Insulet commercialized its first Omnipod product in 2005 and has since evolved from a niche insulin pump manufacturer into a major participant in automated insulin delivery systems. The launch of Omnipod 5, an automated insulin delivery platform integrated with continuous glucose monitoring technology, significantly expanded the company’s competitive position within the digital diabetes management market. Public filings and industry reporting consistently identify Insulet’s tubeless pump design and direct pharmacy distribution model as key differentiators relative to traditional insulin pump competitors.